Wolters Kluwer Health has announced that KLAS Research has recognized the Sentri7® clinical surveillance solution as Best in KLAS® for infection control and monitoring for the second year in a row in the 2023 Best in KLAS: Software and Services report. KLAS Research, which specializes in monitoring and reporting the performance of healthcare vendors, rated Sentri7 as the market leader for infection control for hospitals and health systems.
KLAS interviews thousands of healthcare professionals and uses the responses to rate innovative surveillance software. Evaluation questions cover several areas including Culture, Loyalty, Operations, Product features, Relationship, and Value. Respondents to this year’s survey noted a number of key benefits for using Sentri7, including tailored workflows and features that save time-strapped infection preventionists.
Wolters Kluwer Sentri7 is designed to deliver real-time alerts and evidence-based guidance so clinical teams deliver the right care at the right time. Even with robust electronic health record (EHR) systems, many hospitals are still challenged with identifying at-risk populations and optimizing infection prevention (IP) and control programs. Sentri7 advanced technology leverages data from the EHR and delivers an IP-tailored workflow to automate infection control and required regulatory reporting so that infection control professionals can focus on improving patient care instead of spending time working with IT or navigating manual processes.
Best in KLAS is a recognition given by KLAS Research to health technology solution providers for outstanding efforts to help healthcare professionals deliver better patient care. The Best in KLAS designation is reserved for the software and services market segments that have the broadest operational and clinical impact on healthcare organizations.
Wolters Kluwer will be honored for Sentri7 and also Emmi for Patient Driven Care Management at the Best in KLAS Show 2023 on April 17, 2023, at HIMSS23 in Chicago, Illinois.
Click here to read the original press release.
